23Feb 2025
Ozoralizumab: A Novel Anti-TNF-α Therapy for Rheumatoid Arthritis

Ozoralizumab: A Novel Anti-TNF-α Therapy for Rheumatoid Arthritis

Ozoralizumab is a next-generation anti-TNF-α biologic for RA. This 38 kDa trivalent NANOBODY® incorporates two anti-TNF-α VHH antibodies and one anti-human serum albumin VHH. Approved in Japan (Dec 2022), its efficacy was confirmed in OHZORA and NATSUZORA trials. However, real-world effectiveness remains under investigation, highlighting the need for further clinical data.

  • #rheumatology

Like

Save

Share